Long-term efficacy and safety of once-monthly Risperidone ISM® in the treatment of schizophrenia: Results from a 12-month open-label extension study
- Resource Type
- Article
- Source
- In
Schizophrenia Research January 2022 239:83-91 - Subject
- Language
- ISSN
- 0920-9964